Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Pacira Pharmaceuticals appoints new CFO

This article was originally published in Scrip

Executive Summary

The US acute care speciality company Pacira Pharmaceuticalshas named James Scibetta chief financial officer. Mr Scibetta has more than 20 years' experience in private and public companies, as well as in investment banking. Most recently he was a consultant to Genzyme following his role as CFO of Bioenvision, which was sold to Genzyme in 2007 for $345 million. Before Bioenvision, Mr Scibetta was executive vice-president and CFO of Merrimack Pharmaceuticals.


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts